AMED
Price
$100.99
Change
+$0.01 (+0.01%)
Updated
Aug 14 closing price
Capitalization
3.32B
73 days until earnings call
AMS
Price
$2.62
Change
+$0.03 (+1.16%)
Updated
Aug 15 closing price
Capitalization
16.9M
87 days until earnings call
Interact to see
Advertisement

AMED vs AMS

Header iconAMED vs AMS Comparison
Open Charts AMED vs AMSBanner chart's image
Amedisys
Price$100.99
Change+$0.01 (+0.01%)
Volume$1.06M
Capitalization3.32B
American Shared Hospital Services
Price$2.62
Change+$0.03 (+1.16%)
Volume$5.04K
Capitalization16.9M
AMED vs AMS Comparison Chart in %
Loading...
AMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMED vs. AMS commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMED is a Hold and AMS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (AMED: $100.99 vs. AMS: $2.62)
Brand notoriety: AMED and AMS are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: AMED: 177% vs. AMS: 50%
Market capitalization -- AMED: $3.32B vs. AMS: $16.9M
AMED [@Hospital/Nursing Management] is valued at $3.32B. AMS’s [@Hospital/Nursing Management] market capitalization is $16.9M. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $92.61B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $3.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMED’s FA Score shows that 0 FA rating(s) are green whileAMS’s FA Score has 0 green FA rating(s).

  • AMED’s FA Score: 0 green, 5 red.
  • AMS’s FA Score: 0 green, 5 red.
According to our system of comparison, AMED is a better buy in the long-term than AMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMED’s TA Score shows that 4 TA indicator(s) are bullish while AMS’s TA Score has 6 bullish TA indicator(s).

  • AMED’s TA Score: 4 bullish, 4 bearish.
  • AMS’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, AMS is a better buy in the short-term than AMED.

Price Growth

AMED (@Hospital/Nursing Management) experienced а +0.05% price change this week, while AMS (@Hospital/Nursing Management) price change was +3.06% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.78%. For the same industry, the average monthly price growth was +0.43%, and the average quarterly price growth was +6.39%.

Reported Earning Dates

AMED is expected to report earnings on Oct 29, 2025.

AMS is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Hospital/Nursing Management (+1.78% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMED($3.32B) has a higher market cap than AMS($16.9M). AMED has higher P/E ratio than AMS: AMED (39.30) vs AMS (12.31). AMED YTD gains are higher at: 11.235 vs. AMS (-17.868). AMED has higher annual earnings (EBITDA): 239M vs. AMS (7.85M). AMED has more cash in the bank: 337M vs. AMS (11.2M). AMS has less debt than AMED: AMS (28M) vs AMED (451M). AMED has higher revenues than AMS: AMED (2.4B) vs AMS (29.2M).
AMEDAMSAMED / AMS
Capitalization3.32B16.9M19,651%
EBITDA239M7.85M3,043%
Gain YTD11.235-17.868-63%
P/E Ratio39.3012.31319%
Revenue2.4B29.2M8,226%
Total Cash337M11.2M3,009%
Total Debt451M28M1,611%
FUNDAMENTALS RATINGS
AMED vs AMS: Fundamental Ratings
AMED
AMS
OUTLOOK RATING
1..100
122
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
10075
SMR RATING
1..100
7981
PRICE GROWTH RATING
1..100
5159
P/E GROWTH RATING
1..100
3697
SEASONALITY SCORE
1..100
3950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMS's Valuation (55) in the Medical Or Nursing Services industry is in the same range as AMED (78). This means that AMS’s stock grew similarly to AMED’s over the last 12 months.

AMS's Profit vs Risk Rating (75) in the Medical Or Nursing Services industry is in the same range as AMED (100). This means that AMS’s stock grew similarly to AMED’s over the last 12 months.

AMED's SMR Rating (79) in the Medical Or Nursing Services industry is in the same range as AMS (81). This means that AMED’s stock grew similarly to AMS’s over the last 12 months.

AMED's Price Growth Rating (51) in the Medical Or Nursing Services industry is in the same range as AMS (59). This means that AMED’s stock grew similarly to AMS’s over the last 12 months.

AMED's P/E Growth Rating (36) in the Medical Or Nursing Services industry is somewhat better than the same rating for AMS (97). This means that AMED’s stock grew somewhat faster than AMS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMEDAMS
RSI
ODDS (%)
Bearish Trend 3 days ago
33%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
51%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bullish Trend 3 days ago
37%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
35%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
47%
Bullish Trend 3 days ago
72%
Declines
ODDS (%)
Bearish Trend 17 days ago
58%
Bearish Trend 17 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 3 days ago
67%
Aroon
ODDS (%)
Bullish Trend 3 days ago
28%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDFS19.350.25
+1.31%
PDF Solutions
NUE145.411.06
+0.73%
Nucor Corp
GBTG7.82N/A
N/A
Global Business Travel Group
LPCN3.03-0.01
-0.43%
Lipocine
MNSB21.30-0.13
-0.61%
MainStreet Bancshares

AMED and

Correlation & Price change

A.I.dvisor tells us that AMED and FMCQF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and FMCQF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMED
1D Price
Change %
AMED100%
N/A
FMCQF - AMED
24%
Poorly correlated
-0.11%
OPCH - AMED
23%
Poorly correlated
-0.32%
EHAB - AMED
21%
Poorly correlated
+2.30%
USPH - AMED
21%
Poorly correlated
-0.23%
BKD - AMED
20%
Poorly correlated
-0.27%
More

AMS and

Correlation & Price change

A.I.dvisor tells us that AMS and FMS have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMS and FMS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMS
1D Price
Change %
AMS100%
+1.35%
FMS - AMS
21%
Poorly correlated
+0.84%
EHC - AMS
20%
Poorly correlated
+0.61%
CCM - AMS
6%
Poorly correlated
-1.89%
HCSG - AMS
4%
Poorly correlated
-0.46%
AMED - AMS
1%
Poorly correlated
N/A
More